Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial [NA]
The study reports results from an 8-week randomized trial evaluating a herbal supplement's effect on fatigue and disease activity in systemi…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating the safety of litifilimab injections and whether they can improve sy…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: " TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus
A clinical trial led by South Valley University is investigating TREX1 gene mutations and their role in systemic lupus erythematosus. Recrui…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: The Effect of Clinical Pilates Training on Fatigue, Emotional State, Functional Capacity, Sleep and Quality of Life in Women With Systemic Lupus Erythematosus [NA]
A clinical trial studying whether clinical Pilates training affects fatigue, emotional state, functional capacity, sleep, and quality of lif…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
CorEvitas is conducting a systemic lupus erythematosus drug safety and effectiveness registry. The study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Omega-3 Supplementation in Systemic Lupus Erythematosus [NA]
This clinical trial update notes a study in systemic lupus erythematosus evaluating omega-3 supplementation, sponsored by the University of …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) [Phase 2]
Phase 2 trial evaluating mesenchymal stem cells for systemic lupus erythematosus has completed enrollment (MiSLE).
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating YK012 for moderate to severe Systemic Lupus Erythematosus is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE [NA]
A completed clinical trial evaluating whole-health empowerment to improve quality of life in systemic lupus erythematosus. The study investi…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial evaluating anti-CD19 CAR-T cell therapy for refractory systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE [Phase 1]
Phase 1 clinical trial evaluating an ultra-fast BCMA/CD70 CAR-T therapy for refractory Systemic Lupus Erythematosus; the study is currently …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain [NA]
A clinical trial assessing a multi-component, person-centered, and yoga-based coaching program aimed at reducing pain in people with systemi…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 targeted CD19 CAR-T therapy trial for autoimmune diseases has been suspended.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease [Phase 1]
Phase 1 clinical trial update for a CAR T-cell therapy targeting CD19 and BCMA in autoimmune conditions, with recruiting status and potentia…
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]
A early Phase 1 study of RD06-04 in active autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Study During Pregnancy of Expression of miRNAs in RA or SLE
A completed clinical trial from University Hospital Strasbourg studying the expression of microRNAs during pregnancy in patients with rheuma…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus [NA]
A clinical trial evaluating anti-CD19 CAR-T cell therapy for moderate to severe active systemic lupus erythematosus has been suspended.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases [NA]
This entry describes an ongoing clinical trial at University Hospital, Bordeaux evaluating whether immune mediators and metabolites can stra…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.
This clinical trial update compares the efficacy and safety of telitacicept versus belimumab for systemic lupus erythematosus, based on prio…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
Early-phase clinical study of a targeted CD19/BCMA CAR-T therapy for autoimmune diseases is recruiting, including systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.
A prospective comparative study will evaluate the efficacy and safety of Telitacicept and Belimumab in systemic lupus erythematosus. The stu…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus [Phase 4]
A Phase 4 clinical trial is investigating the efficacy and safety of IL-1 inhibitors for mild to moderate systemic lupus erythematosus and i…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM) [Phase 1]
A Phase 1 trial update indicates Nanjing Legend Biotech is recruiting for LUCAR-G79D to treat relapsed/refractory systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy Study
A completed Canadian real-world study evaluating the burden of lupus from the patient perspective using patient-reported outcomes. It focuse…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial update evaluating litifilimab (BIIB059) for systemic lupus erythematosus, focusing on safety and potential symptom …